Francesco Micheli

Francesco Micheli appears in our data through filings on Intercept Pharmaceuticals, Inc. shares, published by SEC (Form 4). The record holds 12 filings, for trades running from 15 October 2013 to 17 August 2020.

On the open market, the record shows 1 purchase worth €20.3M and 10 sales worth €313.6M. Taken together, the sales exceed the purchases by €293.3M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 1 share grant. 2020 to date brings no purchases and 5 sales.

The latest filing, published on 17 August 2020, reports an open-market sale of €3.7M in Intercept Pharmaceuticals, Inc. The last insider purchase was made public on 9 April 2018, 3,136 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.